MedPath

Evaluation of the alteration of spiroergometric parameters for CAD-patients after recanalization of chronic occluded coronary arteries (CTO)

Not Applicable
Conditions
Chronic Total coronary occlusions
I25.11
Registration Number
DRKS00009293
Lead Sponsor
Helios ForschungszentrumHelios Research Center GmbH Berlin Deutschland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

diagnosis: atherosclerotic hearts disease with one ore more Chronic Total coronary occlusions
-demonstration of a chronic occluded main vessel with clinical symptoms (angina pectoris, dyspnoea, cardiac insufficiency) independent from severity and length of disease
- proof of vitality of the less perfused supply zone of the myocardium
- for our study we only recruit patient with successful coronary vessel recanalization

Exclusion Criteria

- refusal of the spiroergometry for several reasons (pre-existing orthopedic, pulmonic, neurologic diseases) that make an adequate stress impossible
- expected incompliance due to the target stress level, the optimum medical therapy or fulfilment of medical appointments
- additional coronary interventions during the observation period
-malignant diseases and other accompanying diseases which might lead to a reduced physical resilience for other reasons
- participation in another clinical trial
- all patients who did not get an optimum medical therapy
- patient with newly-discovered severe diseases
- severe vitiums
- pregnancy or lactation
- existing addictive disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of the maximum oxygen uptake during spiroergometry 6 months after CTO
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath